News
-
-
PD breaking news – API profit down 14.4% due to “suppressed retail conditions”
Thursday | Apr 19 2018Priceline brand impacted by poor consumer sentiment.
-
King review outcome soon
Wednesday | Apr 18 2018HEALTH Minister Greg Hunt has confirmed that the government's response to the controversial King Review of Pharmacy Remuneration and Regulation will be handed down in about four weeks' time.
-
New ‘Pharmacy to Home’ service
Wednesday | Apr 18 2018THE Pharmacy Guild of Australia has announced the establishment of a strategic partnership with supply chain solutions company Kings Group to launch its Pharmacy to Home Delivery Service through Gold Cross Products and Services.
-
Professional services training – APP2018
Wednesday | Apr 18 2018A CPD-ACCREDITED, pre-conference workshop open to Guild Member pharmacies will be held prior to APP2018 on Wed 02 May outlining how to make professional services a priority in community pharmacy.
-
AHPRA accreditation
Wednesday | Apr 18 2018NATIONAL Boards and AHPRA are consulting on future accreditation arrangements from mid-2019, when the current term of assignment of accreditation functions ends.
-
HCP immunisation
Wednesday | Apr 18 2018IMMUNISATION of healthcare professionals (HCPs) is critically important to preventing disease according to the findings of the Nov 2017 National Foundation for Infectious Diseases (NFID) HCP Immunisation Summit.
-
ACSS consortium
Wednesday | Apr 18 2018A COLLABORATIVE inititative of "like-minded, medium-sized regulatory authorities" has been established, comprising Australia's Therapeutic Goods Administration, Health Canada, Singapore's Health Sciences Authority and the Swiss Agency for Therapeutic Products (Swissmedic) of Switzerland.
-
UK pharmacy defence
Wednesday | Apr 18 2018NEW legislation has come into force in Great Britain, giving a defence from criminal prosecution for pharmacists who make an inadvertent dispensing error.
-
Fake meds danger
Wednesday | Apr 18 2018THE Therapeutic Goods Administration (TGA) has issued an alert around the dangers associated with consumption of two counterfeit medicines being promoted online.
